<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Postgrad Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Postgrad Med</journal-id>
      <journal-id journal-id-type="publisher-id">JPGM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Postgraduate Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-3859</issn>
      <issn pub-type="epub">0972-2823</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26440400</article-id>
      <article-id pub-id-type="pmc">4943375</article-id>
      <article-id pub-id-type="publisher-id">JPGM-61-267</article-id>
      <article-id pub-id-type="doi">10.4103/0022-3859.166519</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Koul</surname>
            <given-names>AN</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Koul AN, E-mail: <email xlink:href="ajazkoul@yahoo.com">ajazkoul@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>61</volume>
      <issue>4</issue>
      <fpage>267</fpage>
      <lpage>267</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Journal of Postgraduate Medicine</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Sir,</p>
    <p>I want to make following observations regarding the article, &#x201C;a case of probable bemiparin-induced heparin-induced thrombocytopenia (HIT) type II managed with low-dose fondaparinux&#x201D; published in your esteemed journal.</p>
    <p>
<list list-type="order"><list-item><p>The profile of the patient is not completely recorded. Patient in question may have thrombocytopenia due to sepsis or ischemic abdomen with disseminated intravascular coagulation. She has abdominal pain, high lactate dehydrogenase, respiratory alkalosis, and the cause for her pain is not ascertained. As this patient had undergone surgery recently, there could be multiple causes for low platelet count</p></list-item><list-item><p>Fondaparinux is not a drug of choice for HIT. It is advisable to use direct thrombin inhibitors like argatroban or bivalirudin. They are Food and Drug Administration (FDA) approved drugs to be used in patients of thrombosis with HIT. Novel anticoagulant drugs such as rivaroxaban, dabigatran, and apixaban are being used as an alternative therapy for HIT but are not FDA approved, nor American College of Chest Physicians recommends them. Fondaparinux is recommended to be used in pregnant patients who develop HIT[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>]</p></list-item><list-item><p>The authors have replaced fondaparinux with acenocoumarol after some time without overlap therapy. Such a step could have increased the risk of paradoxical thrombosis or skin necrosis in protein C or S deficiency.[<xref rid="ref2" ref-type="bibr">2</xref>]</p></list-item></list>
</p>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Cuker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crowther</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical Practice Guideline on the Evaluation and Management of Adults with Suspected Heparin-Induced Thrombocytopenia (HIT)</article-title>
          <year>2013</year>
          <date-in-citation>Last accessed on 2014 Apr</date-in-citation>
          <comment>Available from: <uri xlink:type="simple" xlink:href="http://www.hematology.org/...Ref/529.aspx">http://www.hematology.org/...Ref/529.aspx</uri></comment>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cines</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>How I treat heparin-induced thrombocytopenia</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>119</volume>
          <fpage>2209</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">22246036</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
